ANRO
NYSE · Pharmaceuticals
Alto Neuroscience Inc
$21.87
-1.43 (-6.14%)
Open$23.06
Previous Close$23.30
Day High$23.51
Day Low$21.83
52W High$37.48
52W Low$10.20
Volume—
Avg Volume560.3K
Market Cap886.87M
P/E Ratio—
EPS$-2.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+1.4% upside
Current
$21.87
$21.87
Target
$22.17
$22.17
$14.63
$22.17 avg
$27.87
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 112.34M | 107.15M | 117.41M |
| Net Income | 25.21M | 21.35M | 24.46M |
| Profit Margin | 22.4% | 19.9% | 20.8% |
| EBITDA | 29.11M | 29.85M | 33.13M |
| Free Cash Flow | 25.43M | 19.85M | 18.41M |
| Rev Growth | +16.8% | +14.3% | +23.4% |
| Debt/Equity | 0.26 | 0.26 | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |